LAPLACE: TIMI 57 - A Double-Blind, Randomized, Placebo-controlled, Multicenter, Dose- ranging Study to Evaluate Tolerability and Efficacy of AMG 145 on LDL-C in Combination with HMG-CoA Reductase Inhibitorsin Hypercholesterolemic Subjects